Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3113 results found
Expand All
Apply All
3113 results found

From Prep to Partnership: A Guide to BIO 2025 Meetings
Share
Webinars  •  May 7, 2025
BIO 2025 is around the corner—and with thousands of potential partners and limited time, preparation is everything. Whether you're a first-time attendee or a seasoned BIO veteran, this webinar will give you the tools and strategies to maximize your efforts—from communicating your objectives and optimizing your company profile to crafting compelling meeting requests and making the most of your time onsite. Hear directly from industry panelists as they share insights and real-world advice drawn from their own BIO experiences. Learn what works, what doesn’t, and how to position yourself for success. In this webinar, you'll learn: Best practices for building a standout BIO Partnering™ profile Tips for searching/identifying the right partners and prioritizing your outreach Do’s and don’ts for effective in-person meetings at BIO 2025 What to expect onsite and how to follow up for long-term impact Key BIO Convention updates including networking opportunities and key delegationsVisit convention.bio.org to register or learn more. 
Read More
Partnering and Networking

What BIO's watching in the states
Share
Good Day BIO Newsletter  •  May 5, 2025
Today, we take a deep dive into what’s been happening in the state legislatures—here’s what BIO’s watching related to healthcare and agriculture. Plus, two bills designed to strengthen U.S. patents were introduced May 1. (790 words, 3 minutes, 57 seconds)
Read More

Newsletter Sign Up
Share
BIO Business Solutions

ORPHAN Cures Act: Protecting New Treatments for Patients with Rare Diseases
Share
Human Health, Disease Area  •  Toolkit  •  May 2, 2025
The ORPHAN Cures Act reaffirms Congress’s strong, bipartisan commitment to protect the research and development of new treatments for patients with rare diseases. A rare disease is one that affects fewer than 200,000 people, and while that may seem small, the facts show rare diseases are far from rare.
Read More

BioSafe
Share
Since 2003, BioSafe, BIO's preclinical safety committee, has been driving innovation in biopharmaceuticals by addressing key regulatory and scientific issues. With over 300 members, we focus on expediting time to market and collaborate closely with BIO’s Cell and Gene Therapy Non-Clinical Task Force.
Read More

BIO campaign: ‘Invest in America. Vaccinate’
Share
Good Day BIO Newsletter  •  April 28, 2025
BIO launches a new campaign to explain why we vaccinate – and why it's good for America. We have details, plus how drug companies are investing in U.S. manufacturing, news on drug prices and IP, and more. (740 words, 3 minutes, 42 seconds)
Read More

Getting to Yes: Strategies, Practices, and Tips to Turn Your Partnering Meeting Requests into Meetings
Share
Webinars  •  April 24, 2025
More than 400,000 meetings are requested in the weeks leading up to the BIO International Convention. View this insightful webinar designed to help service providers optimize their approach to business development meetings at the BIO International Convention and turn their meeting requests into productive meetings. Learn how to leverage the BIO Partnering™ system effectively to connect with the right prospects, craft compelling meeting requests, and maximize your networking opportunities. Our panelists share proven strategies, best practices, and insider tips to help you enhance your business development efforts and drive meaningful connections in the life sciences industry. This webinar is tailored to our attendees who represent service providers and vendors, but is open to anyone who believes they can benefit from hearing from experienced sales professionals. 
Read More
Scheduling Meeting image

EO on drug pricing, outlook for pharma tariffs, and more
Share
Good Day BIO Newsletter  •  April 21, 2025
A busy April is flying by. Today, we look at the executive order on drug pricing, the threat of pharmaceutical tariffs, a CDC meeting on immunization practices, and BIO’s appearances at many conferences across the U.S. (750 words, 3 minutes, 45 seconds)
Read More

Leveraging Success to Navigate Commercialization in a Dynamic Global Environment
Share
Webinars  •  April 17, 2025
View this webinar for an in-depth exploration of today's complex global market landscape. This panel will address the challenges of launching new therapies in multiple countries, focusing on early decision points for risk mitigation and maximizing supply chain resiliency. Discover how Cencora's global capabilities and flexible solutions can strengthen supply chain resilience amidst evolving challenges. Moderator: Sandra Anderson, Senior Vice President Commercialization, CencoraPanelists:Glenn Pauly, Chief Commercial Officer, AlzheonGraham Goodrich, Chief Commercial Officer, ApnimedLeigh Shultz, PhD, Associate Vice President & International Head of Trade Channel Strategy & Enablement, Merck & Co.Kevin McDermott, Vice President International Commercialization, CencoraTom Doyle, Head of U.S. Commercial Solutions, Cencora
Read More
BIO-International-global-market

Preserving U.S. biotech leadership is national security priority, says NSCEB
Share
Good Day BIO Newsletter  •  April 14, 2025
Today, we have details on the National Security Commission on Emerging Biotechnology’s new report—and why tariffs still threaten biotech, including pharma and ag. (816 words, 4 minutes, 4 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 13
  • 14
  • 15
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO